These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9093713)

  • 21. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
    Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Hochhaus A; Heinze B
    Blood; 1994 Dec; 84(12):4064-77. PubMed ID: 7994025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
    Steegmann JL; Granados E; Rodríguez-Salvanés F; Casado LF; Giraldo P; Lavilla E; Gómez-Casares MT; Fernández-Contreras E; Odriozola J
    Sangre (Barc); 1998 Apr; 43(2):137-46. PubMed ID: 9656775
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results.
    Alimena G; Meloni G; de Cuia MR; Rondinelli MB; Lo Coco F; Montefusco E; Mancini M; Pinto R; Nanni M; Cedrone M
    Leuk Lymphoma; 1993; 11 Suppl 1():281-91. PubMed ID: 7902746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
    Petukhov VI; Strozha IL; Bondare DK
    Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
    [No Abstract]   [Full Text] [Related]  

  • 26. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
    Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
    Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow transplantation for chronic myeloid leukaemia.
    Goldman JM
    Bone Marrow Transplant; 1991; 7 Suppl 2():62-3. PubMed ID: 1878724
    [No Abstract]   [Full Text] [Related]  

  • 30. Hematologic and cytogenetic remission by STI571 (Glivec) in a patient relapsing with accelerated phase CML after second allogeneic stem cell transplantation.
    Wassmann B; Klein SA; Scheuring U; Pfeifer H; Martin H; Gschaidmeier H; Hoelzer D; Ottmann OG
    Bone Marrow Transplant; 2001 Oct; 28(7):721-4. PubMed ID: 11704799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on therapy for chronic myelogenous leukemia.
    Weinberger BB
    J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.
    Buño I; Wyatt WA; Zinsmeister AR; Dietz-Band J; Silver RT; Dewald GW
    Blood; 1998 Oct; 92(7):2315-21. PubMed ID: 9746769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis.
    Leber B; Walker IR; Rodriguez A; McBride JA; Carter R; Brain MC
    Bone Marrow Transplant; 1993 Oct; 12(4):405-7. PubMed ID: 8275041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
    Martinelli G; Testoni N; Amabile M; Bonifazi F; De Vivo A; Farabegoli P; Terragna C; Montefusco V; Ottaviani E; Saglio G; Russo D; Baccarani M; Rosti G; Tura S
    Bone Marrow Transplant; 2000 Apr; 25(7):729-36. PubMed ID: 10745258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment choices in chronic myelogenous leukemia.
    Ready N; Freeman NJ; Carvalho A
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):95-8, 101. PubMed ID: 1522171
    [No Abstract]   [Full Text] [Related]  

  • 37. Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia.
    Holowiecki J; Giebel S; Wojnar J; Krawczyk-Kulis M; Markiewicz M; Holowiecka-Goral A; Freund M; Casper J
    Br J Haematol; 2008 Jun; 142(2):284-92. PubMed ID: 18492101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic myeloid leukemia: management of relapse after allogeneic bone marrow transplantation.
    Kumar L
    Leuk Lymphoma; 1993 Jun; 10(3):165-71. PubMed ID: 8220114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia.
    Huang XJ; Xu LP; Liu KY; Liu DH; Chen H; Liu YR; Chen YH; Han W; Wang Y
    Biol Blood Marrow Transplant; 2011 May; 17(5):649-56. PubMed ID: 20691800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approaches to the treatment of chronic myeloid leukemia.
    Savage DG; Goldman JM
    Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.